SCHEMBL16685199

SCHEMBL16685199

OCCC[C@H](O)CC#CCOC1CCCCO1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GCK P35557 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23023778 1.00 MEN1 (0.33) MEN1KMT2AGCK
SCHEMBL12911516 0.85 GCK (0.34) MEN1KMT2AGCK
SCHEMBL18047458 0.82 GCK (0.35) MEN1KMT2AGCK
SCHEMBL16693378 0.82 GCK (0.31) GCK
SCHEMBL16685525 0.82 GCK (0.35) MEN1KMT2AGCK
SCHEMBL16685394 0.82 GCK (0.31) GCK
SCHEMBL16693263 0.81 GCK (0.35) MEN1KMT2AGCK
SCHEMBL16685353 0.81 GCK (0.35) MEN1KMT2AGCK
SCHEMBL16685352 0.81 ACACB (0.45) MEN1KMT2AGCK
SCHEMBL9724464 0.80 MEN1 (0.36) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11643418-B2 Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2023-05-09 US disclosed
US-11643418-B2 Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2023-05-09 US disclosed
CN-114716453-A Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B 卫材R&D管理有限公司 2022-07-08 CN disclosed
CN-109942560-B Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B 卫材R&D管理有限公司 2022-06-17 CN disclosed
EP-3689881-B1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B EISAI R&D MAN CO LTD (JP) 2022-01-12 EP disclosed
US-20210188867-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2021-06-24 US disclosed
US-10934307-B2 Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2021-03-02 US disclosed
EP-3689881-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B Eisai R&D Management Co., Ltd. (JP) 2020-08-05 EP disclosed
US-20200223864-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2020-07-16 US disclosed
US-10611773-B2 Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2020-04-07 US disclosed
US-20180002342-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2018-01-04 US disclosed
US-9783549-B2 Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2017-10-10 US disclosed
US-9783549-B2 Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2017-10-10 US disclosed
US-9783549-B2 Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2017-10-10 US disclosed
US-20160264594-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2016-09-15 US disclosed
US-20160264594-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2016-09-15 US disclosed
US-20160264594-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2016-09-15 US disclosed
EP-3066102-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B Eisai R&D Management Co., Ltd. (JP) 2016-09-14 EP disclosed
WO-2015066729-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-05-07 WO disclosed
WO-2015066729-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-05-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180002342-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B ERLIN1, DHPS, ELOB MEN1 214/4885KMT2A 4155/4885GCK 730/4885
US-20160264594-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B ERLIN1, DHPS, ELOB MEN1 166/4885KMT2A 4122/4885GCK 559/4885
US-20200223864-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B ERLIN1, MAN1B1, DHPS MEN1 131/4885KMT2A 4252/4885GCK 817/4885
US-10934307-B2 Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B ERLIN1, MAN1B1, DHPS MEN1 131/4885KMT2A 4252/4885GCK 817/4885
US-11643418-B2 Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B ERLIN1, MAN1B1, DHPS MEN1 92/4885KMT2A 4203/4885GCK 608/4885
US-10611773-B2 Macrocyclization reactions and intermediates and other fragments useful in the synthesis of analogs of halichondrin B ERLIN1, MAN1B1, DHPS MEN1 131/4885KMT2A 4252/4885GCK 817/4885
US-20210188867-A1 MACROCYCLIZATION REACTIONS AND INTERMEDIATES AND OTHER FRAGMENTS USEFUL IN THE SYNTHESIS OF ANALOGS OF HALICHONDRIN B ERLIN1, MAN1B1, DHPS MEN1 92/4885KMT2A 4203/4885GCK 608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.